Download our Medsii App
PharmaSentinel is a member of the NVIDIA Inception Program
Case Studies
Fabrizio Ballantini - Chief Executive Officer PharmaSentinel
Fabrizio Ballantini, the Chief Executive Officer of PharmaSentinel on how leading pharmaceutical companies are using our flagship AI-driven Medsii.com product today to discover faster medicines intelligence, save costs and free up valuable resources to focus on higher-value activities.
What We Do
PharmaSentinel's technology leverages AI to deliver rapid, timely, personalized regulatory & scientific medicines intelligence in a mobile-first award-winning user interface.
Our platform is robust, scalable, secure and GDPR compliant
PharmaSentinel - Delivering Faster Trusted Medicines Intelligence
Pharma Sentinel's Flagship Product Medsii In Use By Multiple Pharmaceutical Companies
Webby Honoree 2021 - Health & Fitness Category
Contact Us
Please reach out to us with any questions about our AI-driven medicines news information service.
Featured Products
PharmaSentinel Ltd
Copyright © 2026 PharmaSentinel Ltd. - All Rights Reserved.
© 2026 NVIDIA, the NVIDIA logo, and the NVIDIA Inception Program are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.